NCT06164431View on ClinicalTrials.gov

Bioavailability Study in Healthy Participants, 200mg Tablets ZSP1273 Versus 200mg Granules ZSP1273

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

November 23, 2023

Primary Completion Date

December 15, 2023

Study Completion Date

December 22, 2023

Conditions
Bioequivalence
Interventions
DRUG

ZSP1273 tablet

Participants receive ZSP1273 tablet orally.

DRUG

zsp1273 granules

Participants receive ZSP1273 granules orally.

Trial Locations (1)

Unknown

Guangdong Hospital of Chinese Medicine, Guangzhou

All Listed Sponsors
lead

Guangdong Raynovent Biotech Co., Ltd

INDUSTRY

NCT06164431 - Bioavailability Study in Healthy Participants, 200mg Tablets ZSP1273 Versus 200mg Granules ZSP1273 | Biotech Hunter | Biotech Hunter